TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
136 hedge funds and large institutions have $83.3M invested in Tvardi Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 47 increasing their positions, 37 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
-27
Holders Change %
-16.56%
% of All Funds
2.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
47
Reduced
37
Closed
47
Calls
$327K
Puts
$37K
Net Calls
+$290K
Net Calls Change
-$219K
Top Buyers
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.89M |
| 2 |
Millennium Management
New York
|
+$2.07M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$1.77M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$1.67M |
| 5 |
ClearBridge Investments
New York
|
+$1.45M |
Top Sellers
| 1 |
BlackRock
New York
|
-$11M |
| 2 |
KCM
Kingdon Capital Management
New York
|
-$6.05M |
| 3 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$3.59M |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.78M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.54M |
